Logo image of CTZ.CA

NAMSYS INC (CTZ.CA) Stock Fundamental Analysis

Canada - TSX-V:CTZ - CA6300001071 - Common Stock

1.23 CAD
-0.02 (-1.6%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

7

Overall CTZ gets a fundamental rating of 7 out of 10. We evaluated CTZ against 62 industry peers in the Software industry. Both the health and profitability get an excellent rating, making CTZ a very profitable company, without any liquidiy or solvency issues. CTZ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CTZ had positive earnings in the past year.
CTZ had a positive operating cash flow in the past year.
CTZ had positive earnings in 4 of the past 5 years.
CTZ had a positive operating cash flow in 4 of the past 5 years.
CTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFCTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

CTZ has a Return On Assets of 21.71%. This is amongst the best in the industry. CTZ outperforms 93.55% of its industry peers.
Looking at the Return On Equity, with a value of 23.80%, CTZ belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
CTZ has a Return On Invested Capital of 21.30%. This is amongst the best in the industry. CTZ outperforms 95.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTZ is significantly above the industry average of 12.35%.
The last Return On Invested Capital (21.30%) for CTZ is above the 3 year average (20.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 21.71%
ROE 23.8%
ROIC 21.3%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
CTZ.CA Yearly ROA, ROE, ROICCTZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

Looking at the Profit Margin, with a value of 31.45%, CTZ belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
CTZ's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 39.48%, CTZ belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CTZ has declined.
CTZ has a Gross Margin of 64.31%. This is in the better half of the industry: CTZ outperforms 70.97% of its industry peers.
In the last couple of years the Gross Margin of CTZ has remained more or less at the same level.
Industry RankSector Rank
OM 39.48%
PM (TTM) 31.45%
GM 64.31%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
CTZ.CA Yearly Profit, Operating, Gross MarginsCTZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CTZ is creating value.
CTZ has less shares outstanding than it did 1 year ago.
CTZ has less shares outstanding than it did 5 years ago.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTZ.CA Yearly Shares OutstandingCTZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CTZ.CA Yearly Total Debt VS Total AssetsCTZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

CTZ has an Altman-Z score of 23.55. This indicates that CTZ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.55, CTZ belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 23.55
ROIC/WACC2
WACC10.65%
CTZ.CA Yearly LT Debt VS Equity VS FCFCTZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 11.36 indicates that CTZ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.36, CTZ belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
CTZ has a Quick Ratio of 11.36. This indicates that CTZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CTZ (11.36) is better than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 11.36
Quick Ratio 11.36
CTZ.CA Yearly Current Assets VS Current LiabilitesCTZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

CTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.68%, which is quite impressive.
The Earnings Per Share has been growing by 9.78% on average over the past years. This is quite good.
Looking at the last year, CTZ shows a quite strong growth in Revenue. The Revenue has grown by 18.05% in the last year.
The Revenue has been growing by 10.68% on average over the past years. This is quite good.
EPS 1Y (TTM)23.68%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%7.08%
Revenue 1Y (TTM)18.05%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%10.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTZ.CA Yearly Revenue VS EstimatesCTZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.67, CTZ is valued correctly.
90.32% of the companies in the same industry are more expensive than CTZ, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.29. CTZ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.67
Fwd PE N/A
CTZ.CA Price Earnings VS Forward Price EarningsCTZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTZ indicates a rather cheap valuation: CTZ is cheaper than 93.55% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CTZ is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.72
EV/EBITDA 4.93
CTZ.CA Per share dataCTZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

The excellent profitability rating of CTZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.4
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CTZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAMSYS INC

TSX-V:CTZ (10/16/2025, 7:00:00 PM)

1.23

-0.02 (-1.6%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-25 2025-09-25
Earnings (Next)02-17 2026-02-17
Inst Owners21.43%
Inst Owner ChangeN/A
Ins Owners8.17%
Ins Owner ChangeN/A
Market Cap33.11M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.67
Fwd PE N/A
P/S 4.29
P/FCF 15.72
P/OCF 15.65
P/B 3.24
P/tB 3.24
EV/EBITDA 4.93
EPS(TTM)0.09
EY7.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY6.36%
OCF(TTM)0.08
OCFY6.39%
SpS0.29
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)1.4
Profitability
Industry RankSector Rank
ROA 21.71%
ROE 23.8%
ROCE 29.87%
ROIC 21.3%
ROICexc 328.31%
ROICexgc 328.31%
OM 39.48%
PM (TTM) 31.45%
GM 64.31%
FCFM 27.27%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
ROICexc(3y)454.3%
ROICexc(5y)N/A
ROICexgc(3y)454.3%
ROICexgc(5y)N/A
ROCE(3y)29.1%
ROCE(5y)33.64%
ROICexcg growth 3Y-15.99%
ROICexcg growth 5Y13.62%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y13.62%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 132.88%
Cap/Sales 0.13%
Interest Coverage 250
Cash Conversion 69.23%
Profit Quality 86.71%
Current Ratio 11.36
Quick Ratio 11.36
Altman-Z 23.55
F-Score5
WACC10.65%
ROIC/WACC2
Cap/Depr(3y)76.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)96.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.68%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%7.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.05%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%10.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.21%
EBIT growth 3Y12.01%
EBIT growth 5Y8.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.15%
FCF growth 3YN/A
FCF growth 5Y12.45%
OCF growth 1Y38.32%
OCF growth 3YN/A
OCF growth 5Y12.31%